长春新碱
美罗华
强的松
套细胞淋巴瘤
苯达莫司汀
环磷酰胺
医学
内科学
切碎
肿瘤科
淋巴瘤
化疗
出处
期刊:Blood
[Elsevier BV]
日期:2014-05-08
卷期号:123 (19): 2905-2906
被引量:1
标识
DOI:10.1182/blood-2014-03-562124
摘要
In this issue of Blood , Flinn et al report a phase 3 study demonstrating similar complete response rates with bendamustine and rituximab compared with rituximab plus cyclophosphamide, adriamycin, vincristine, and prednisone (R-CHOP) or rituximab plus cyclophosphamide, vincristine, and prednisone (R
科研通智能强力驱动
Strongly Powered by AbleSci AI